Sign In
Buy SNGX
$0.362
-0.0003 (-0.0829%)
At Close: Jul 28, 2026
Soligenix To Test Synthetic Hypericin In Psoriasis Patients
01:14pm, Thursday, 16'th Sep 2021
Soligenix Inc (NASDAQ: SNGX) says that following the validation of synthetic hypericin's biologic activity, the Company will be expanding the therapy under the research name SGX302 into psoriasis.
Soligenix to Advance Synthetic Hypericin Development in Psoriasis
08:22am, Thursday, 16'th Sep 2021
PRINCETON, N.J., Sept. 16, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
SNGX Stock: The Big FDA News Giving Biotech Penny Stock Soligenix a Boost
01:46pm, Thursday, 09'th Sep 2021
Soligenix (SNGX) stock is roaring higher on Thursday thanks to some positive news from the U.S. Food and Drug Administration today. The post SNGX Stock: The Big FDA News Giving Biotech Penny Stock Sol
SNGX Stock: Why It Increased Today
10:50am, Thursday, 09'th Sep 2021
The stock price of Soligenix, Inc. (NASDAQ: SNGX) increased by more than 13% during intraday trading today. This is why it happened.
Soligenix Stock Moves Higher On US Orphan Drug Tag For T-cell Lymphoma Candidate
09:58am, Thursday, 09'th Sep 2021
The FDA has granted orphan drug designation to the active ingredient hypericin to treat T-cell lymphoma, extending the target population beyond cutaneous T-cell lymphoma (CTCL) as previously granted
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
07:30am, Thursday, 09'th Sep 2021
PRINCETON, N.J., Sept. 9, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital Biotech Watch Review
08:30am, Tuesday, 24'th Aug 2021
NEW YORK, Aug. 24, 2021 /PRNewswire/ -- Vaccines are known for the stringent cold chain storage requirements necessary to maintain their integrity. In the U.S., maintaining refrigerated or frozen cond
PRINCETON, N.J., Aug. 23, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix Unveils Preclinical Data From Filovirus Vaccine Candidates
11:41am, Wednesday, 18'th Aug 2021
Soligenix Inc (NASDAQ: SNGX) announced positive preclinical data from its filovirus vaccine candidates, including thermostabilized multivalent vaccines in a single vial platform presentation. Data
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
08:52am, Wednesday, 18'th Aug 2021
PRINCETON, N.J., Aug. 18, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
07:30am, Friday, 13'th Aug 2021
PRINCETON, N.J., Aug. 13, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma
08:30am, Thursday, 22'nd Jul 2021
Soligenix Demonstrates Clinical Success in First-in-Class Treatment for Cutaneous T-Cell LymphomaNew York, New York--(Newsfile Corp. - July 22, 2021) - PCG Digital -- Cutaneous T-cell lymphoma (CTCL)
7 Reddit Penny Stocks to Bet On if You Have $100 to Gamble
02:12pm, Monday, 12'th Jul 2021
Reddit traders aren't just focused on short squeezes. Here are seven ultra-risky Reddit penny stocks that have caught their attention.
Offering New Hope for a Rare Form of non-Hodgkin's Lymphoma: A Discussion with Dr. Ellen Kim on HyBryte(TM) from Soligenix
08:30am, Tuesday, 06'th Jul 2021
New York, New York--(Newsfile Corp. - July 6, 2021) - PCG Digital -- A rare form of non-Hodgkin's lymphoma, cutaneous T-cell lymphoma (CTCL) has no current FDA-approved first-line therapies. There are
PRINCETON, N.J., June 22, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to
